Biotechnology

(As yet, there’s no proven method to rejoin a severed spinal cord.)
[...]
But since making his investment, Wang says, he’s become less bullish. He now views whole-body transplant as “very infeasible, not even very scientific” and “far away from hope for any realistic application.”